Abbas Behzad Behbahani (Abbas Behzad-Behbahani)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Advanced pharmaceutical bulletin

Interdisciplinary perspectives on infectious diseases

Microbiology and immunology

Biotechnology letters

Shiraz University of Medical Sciences

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shiraz University of Medical Sciences

Iran

Head of Research Center :: Diagnostic Laboratory Sciences and Trchnology Research Center

Education History

University of Manchester

United Kingdom

PHD :: Biological Sciences

Publications

Zahra Abbasfard, Abbas Behzad Behbahani, Banafsheh Rastegari, Sirous Naeimi, Parisa Mohamadynejad, Fatemeh Safari
Overcoming Breast Cancer Drug Resistance: A Novel Approach Using siRNA-Mediated P-glycoprotein Downregulation to Enhance Vinorelbine Efficacy. Advanced pharmaceutical bulletin 14 (2) (2024)
Zahra Abbasfard, Abbas Behzad Behbahani, Banafsheh Rastegari, Sirous Naeimi, Parisa Mohamadynejad, Fatemeh Safari
SiRNA-Mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer Cells. Current pharmaceutical biotechnology (2024)
Zahra Abbasfard, Abbas Behzad Behbahani, Banafsheh Rastegari, Sirous Naeimi, Parisa Mohamadynejad, Fatemeh Safari
Overcoming Breast Cancer Drug Resistance: A Novel Approach Using siRNA-Mediated P-glycoprotein Downregulation to Enhance Vinorelbine Efficacy. Advanced pharmaceutical bulletin 14 (2) (2024)
Ali Farhadi, Haniyeh Abuei, Mohammad Ali Okhovat, Bita Geramizadeh, Abbas Behzad Behbahani, Pei Pei Chong, Negin Nikouyan, Sepide Namdari
Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran. Cancer cell international 23 (1) (2023)
Maryam Zare, Ali Farhadi, Farahnaz Zare, Gholamreza Rafiei Dehbidi, Farzaneh Zarghampoor, Mohammad Karimi Baba Ahmadi, Abbas Behzad Behbahani
Genetically engineered E. coli invade epithelial cells and transfer their genetic cargo into the cells: an approach to a gene delivery system. Biotechnology letters (2023)
Sepide Namdari, Pei Pei Chong, Abbas Behzad Behbahani, Bita Geramizadeh, Ali Dehghani Nazhvani, Zamberi Bin Sekawi, Ali Farhadi
Human herpesvirus 6A and 6B and polyomavirus JC and BK infections in renal cell carcinoma and their relationship with p53, p16INK4a, Ki-67, and nuclear factor-kappa B expression. Microbiology and immunology 66 (11) (2022)
Sedigheh Jalali, Ali Farhadi, Gholamreza Rafiei Dehbidi, Shirin Farjadian, Sedigheh Sharifzadeh, Reza Ranjbaran, Noorossadat Seyyedi, Sepide Namdari, Abbas Behzad Behbahani
The Pathogenic Aspects of Human Parvovirus B19 NS1 Protein in Chronic and Inflammatory Diseases. Interdisciplinary perspectives on infectious diseases 2022 (2022)
Sepide Namdari, Ali Farhadi, Aida Khademalhoseini, Abbas Behzad Behbahani, Afsaneh Moaddeb
Emergence of Highly Multidrug-Resistant Bacteria Isolated from Patients with Infections Admitted to Public Hospitals in Southwest Iran. Interdisciplinary perspectives on infectious diseases 2021 (2021)
Haniyeh Abuei, Abbas Behzad Behbahani, Fatemeh Faghihi, Ali Farhadi, Gholam Reza Rafiei Dehbidi, Mohammad Pirouzfar, Farahnaz Zare
The Effect of Bacterial Peptide p28 on Viability and Apoptosis Status of P53-null HeLa Cells. Advanced pharmaceutical bulletin 9 (4) (2019)

Abbas Behzad Behbahani.css-eqlu8i{font-size:small;padding-left:4px;} (Abbas Behzad-Behbahani)

Publication Activity (10 Years)

Top Topics

Top Venues

Abbas Behzad Behbahani (Abbas Behzad-Behbahani)